Hints and tips:
...Jana became a shareholder in the fourth quarter of 2016 and since then chairman Lamberto Andreotti has announced his retirement in May....
...Lamberto Andreotti, BMS chief executive, said: “We are pleased to be able to strengthen the portfolio we have built to help patients with diabetes …The acquisition of Amylin by Bristol-Myers Squibb is also...
...Andreotti, chief executive officer of Bristol....
...In his first interview since taking over from James Cornelius in May, Lamberto Andreotti explained that BMS would pursue and intensify his predecessor’s plans to “not give up the big pharma legacy, and combine...
International Edition